TWI566797B - Liquid transmission device and liquid transmission monitoring device - Google Patents
Liquid transmission device and liquid transmission monitoring device Download PDFInfo
- Publication number
- TWI566797B TWI566797B TW102143162A TW102143162A TWI566797B TW I566797 B TWI566797 B TW I566797B TW 102143162 A TW102143162 A TW 102143162A TW 102143162 A TW102143162 A TW 102143162A TW I566797 B TWI566797 B TW I566797B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid
- liquid medicine
- monitoring device
- pump
- flow
- Prior art date
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
本發明是有關於一種藥液傳輸裝置及藥液傳輸監控裝置,特別是有關於一種拋棄式藥液驅動本體裝設入可攜式控制本體之藥液傳輸(監控)裝置。 The invention relates to a drug liquid transport device and a drug liquid transport monitoring device, in particular to a drug liquid transport (monitoring) device in which a disposable chemical liquid drive body is installed in a portable control body.
目前的藥液傳輸裝置都採用機械式的驅動元件,大都係以藥液耗材裝設入具有驅動器(泵浦)之可攜式控制本體上,惟,當病患或者醫護人員於操作時皆必須進行一系列之設定,例如包括「四小時給藥最大量(Four Hour Limit)、單次藥物輸注量(Bolus Amount)、每次給藥間隔時間(Lockout Time),以及設定是否需要持續輸注藥物的「連續輸注量(Continues Dosage)等等之設定,不僅設定繁瑣且易造成病患或者醫護人員於操作錯誤設定異常時所造成生命危險及身體上難以估計之侵害。 The current medical fluid transport devices use mechanical drive components, most of which are installed in a portable control body with a driver (pump), but only when the patient or medical staff is operating. Perform a series of settings including, for example, "Four Hour Limit", Bolus Amount, Lockout Time, and whether continuous infusion of medication is required. The setting of "Continues Dosage" and the like is not only a cumbersome setting, but also a life-threatening problem that is difficult to be diagnosed by the patient or the medical staff in the case of an abnormal operation setting error.
再者,市面上之藥液傳輸裝置其驅動本體(泵浦)係與控制本體一體製成,而另外與藥液耗材相分離,不僅體積龐大、昂貴,且造成藥液污染於驅動本體(泵浦)上。 Furthermore, the liquid chemical transport device on the market has a driving body (pump) which is integrally formed with the control body, and is separately separated from the medical liquid consumable, which is not only bulky and expensive, but also causes the chemical liquid to be contaminated on the driving body (pump) Pu).
此外,藥液傳輸裝置其驅動本體(泵浦)亦容易因使用年限過久,造成藥液流量輸出異常。 In addition, the driving body (pumping) of the drug solution transmission device is also prone to an abnormality in the flow rate of the drug solution due to the long service life.
另外一提的是,病患或者醫護人員於操作藥液傳輸裝置時,因每一種藥液傳輸裝置介面不盡相同,容易造成使用上之不便,使得病患或者醫護人員產生適用性與生命身體上之安全問題。有鑑於習知技術仍有上述之缺失,發明人乃針對該些缺失研究改進之道,終於有本發明之產生。 In addition, when the patient or medical staff is operating the drug delivery device, the interface of each drug delivery device is not the same, which is easy to cause inconvenience in use, and the patient or medical staff has applicability and life. Security issues. In view of the above-mentioned shortcomings of the prior art, the inventors have finally developed the invention for the improvement of the missing research.
有鑑於上述習知技藝之問題,本發明之其中一目的就是在提供一種藥液傳輸裝置其驅動本體(泵浦)係與藥液耗材一體製成而為可拋棄式藥液驅動本體,該可拋棄式藥液驅動本體另外與控制本體相分離,藉由個別使用可拋棄式之泵浦與輸液管路之藥液各自分離獨立,防止造成藥液污染於驅動本體(泵浦),以及避免驅動本體(泵浦)使用年限過久所造成藥液流量輸出異常。 In view of the above-mentioned problems of the prior art, one of the objects of the present invention is to provide a liquid medicine transport device in which a driving body (pump) system is integrally formed with a liquid medicine supply and is a disposable liquid medicine driving body. The disposable chemical liquid driving body is separately separated from the control body, and the liquids of the pumping and infusion lines are separately separated and separated by using the disposable pump to prevent contamination of the driving body (pumping) and avoiding driving. The body fluid flow output is abnormal due to the long-term use of the body (pump).
根據上述之目的,係在提出一種藥液傳輸裝置,其包含一可攜式控制本體及一拆卸式藥液驅動體。可攜式控制本體係具有一容置空間。拆卸式藥液驅動體係裝設入可攜式控制本體上之容置空間中,拆卸式藥液驅動體具有一輸液管路。輸液管路係存有一藥液,泵浦係鄰近於輸液管路。其中藉由使用者持拆卸式藥液驅動體而組裝入可攜式控制本體,使可攜式控制本體提供一電力予拆卸式藥液驅動體,以提供藥液傳輸之動力。 In accordance with the above objects, a medical fluid delivery device is provided that includes a portable control body and a detachable medical fluid drive. Portable control system has a space for accommodation. The detachable liquid medicine driving system is installed in the accommodating space on the portable control body, and the detachable liquid medicine driving body has an infusion line. There is a liquid in the infusion line, and the pump is adjacent to the infusion line. The portable control body is assembled by the user holding the detachable liquid medicine driving body, so that the portable control body provides a power to the detachable liquid medicine driving body to provide power for liquid medicine transmission.
本發明之其中一目的就是在提供一種藥液傳輸裝置具有泵浦型號識別單元以及複數個藥液傳輸模式,藉由可攜式控制本體加以辯識泵浦型號,控制本體加以對應而選擇出其中一種藥液傳輸模式,例如是麻醉藥傳輸模式、藥液傳輸模式、血液傳輸模式,以及點滴傳輸模式,減少使用上之設定以及使用上之誤差,大幅增加其便利性。 One of the objects of the present invention is to provide a medical fluid transfer device having a pump type identification unit and a plurality of drug liquid transfer modes, wherein the portable control body is used to identify the pump model, and the control body is selected to correspond thereto. A drug delivery mode, such as an anesthetic delivery mode, a drug delivery mode, a blood transfer mode, and a drip transfer mode, which reduces the use setting and the error in use, and greatly increases the convenience.
根據上述之目的,係在提出一種藥液傳輸監控裝置,其包含一可攜式控制本體及拆卸式藥液驅動體。可攜式控制本體係具有一容置空間及一控制單元,控制單元係具有一控制訊號,以控制藥液流量,控制單元具有一泵浦型號偵測單元及複數個藥液傳輸模式。拆卸式藥液驅動體係裝設入可攜式控制本體上之容置空間中,並且利用可攜式控制本體提供電力予拆卸式藥液驅動體。拆卸式藥液驅動體具有一藥液、一泵浦及一資訊傳輸模組,泵浦係藉由該控制訊號控制該泵浦,以控制該藥液之流量,且提供動力加以傳輸藥液。資訊傳輸模組係具有一泵浦型號識別單元,係提供泵浦之一型號識別碼至泵浦型號偵測單元,以對應其中之一藥液傳輸模式,其中藥液傳輸模式更具有藥物操作模式、輸血操作模式及點滴操作模式其中之一。 In accordance with the above objects, a medical fluid delivery monitoring device is provided which includes a portable control body and a detachable medical fluid drive. Portable control system has a housing space and a control unit. The control unit has a control signal to control the flow of the liquid medicine. The control unit has a pump type detecting unit and a plurality of liquid medicine transmission modes. The detachable liquid medicine driving system is installed in the accommodating space on the portable control body, and supplies power to the detachable liquid medicine driving body by using the portable control body. The detachable liquid medicine driving body has a chemical liquid, a pump and an information transmission module, and the pump controls the pump by the control signal to control the flow rate of the liquid medicine, and provides power to transmit the medicine liquid. The information transmission module has a pump type identification unit, which provides one type of pump identification code to the pump type detection unit to correspond to one of the liquid medicine transmission modes, wherein the medicine liquid transmission mode has a drug operation mode. One of the blood transfusion mode and the drip mode.
其中可攜式控制本體更具有一插槽,插槽係插設入一血含氧濃度量測模組(SpO 2),以防止患者在昏迷或是無法自主的狀況下發生致命副作用或併發症。 The portable control body has a slot, and the slot is inserted into a blood oxygen concentration measuring module (SpO 2) to prevent the patient from having a fatal side effect or a complication in a coma or incapable condition. .
其中資訊傳輸模組更具有一流量偵測單元, 其係產生一藥液流量訊號至控制單元,其中控制單元更儲存有複數個流量資料,當藥液流量訊號對應其中之一流量資料時,藥液流量係為異常,使控制單元產生一警示訊號。 The information transmission module further has a flow detection unit. The system generates a liquid flow signal to the control unit, wherein the control unit further stores a plurality of flow data. When the liquid flow signal corresponds to one of the flow data, the flow of the liquid is abnormal, so that the control unit generates a warning signal. .
上述流量偵測單元係具有複數溫度感測器,藉由藥液流經其中之一溫度感測器至另一溫度感測器所產生之溫差,據以量測藥液之流量。 The flow detecting unit has a plurality of temperature sensors for measuring the flow rate of the liquid medicine by a temperature difference generated by the liquid medicine flowing through one of the temperature sensors to the other temperature sensor.
1‧‧‧藥液傳輸裝置 1‧‧‧ drug delivery device
10‧‧‧藥液傳輸監控裝置 10‧‧‧ drug liquid transmission monitoring device
11‧‧‧可攜式控制本體 11‧‧‧Portable Control Body
111‧‧‧容置空間 111‧‧‧ accommodating space
1111‧‧‧導槽 1111‧‧‧ Guide slot
1112‧‧‧第二電性連接點 1112‧‧‧Second electrical connection point
1113‧‧‧第三電訊連接點 1113‧‧‧ Third telecommunications connection point
112‧‧‧控制單元 112‧‧‧Control unit
1121‧‧‧控制訊號 1121‧‧‧Control signal
1122‧‧‧泵浦型號偵測單元 1122‧‧‧Pump type detection unit
1123‧‧‧藥液傳輸模式 1123‧‧‧Drug transfer mode
1124‧‧‧輸血操作模式 1124‧‧‧Transfusion mode of operation
1125‧‧‧點滴操作模式 1125‧‧‧ drip operation mode
1126‧‧‧藥物操作模式 1126‧‧‧ drug operation mode
1127‧‧‧警示訊號 1127‧‧‧ warning signal
1128‧‧‧流量資料 1128‧‧‧Flow data
1129‧‧‧輸液歷程紀錄資訊 1129‧‧‧Infusion history record information
113‧‧‧電力 113‧‧‧Power
114‧‧‧插槽 114‧‧‧Slots
115‧‧‧有/無線傳輸單元 115‧‧‧With /Wireless Transmission Unit
12‧‧‧拆卸式藥液驅動體 12‧‧‧Disassembled liquid driving body
120‧‧‧導軌 120‧‧‧rails
1201‧‧‧開口 1201‧‧‧ openings
1202‧‧‧第二電性接點 1202‧‧‧second electrical contact
1203‧‧‧第四電訊連接點 1203‧‧‧4th telecommunications connection point
121‧‧‧輸液管路 121‧‧‧Infusion line
1211‧‧‧藥液 1211‧‧‧ liquid
122‧‧‧壓電泵浦 122‧‧‧Piezoelectric pump
123‧‧‧資訊傳輸模組 123‧‧‧Information Transmission Module
124‧‧‧泵浦型號識別單元 124‧‧‧Pump Model Identification Unit
1241‧‧‧型號識別碼 1241‧‧‧Model ID
125‧‧‧流量偵測單元 125‧‧‧Flow detection unit
1251‧‧‧預熱器 1251‧‧‧Preheater
1252‧‧‧藥液流量訊號 1252‧‧‧Drug flow signal
1253‧‧‧第一溫度感測器 1253‧‧‧First temperature sensor
1254‧‧‧第二溫度感測器 1254‧‧‧Second temperature sensor
2‧‧‧血含氧濃度量測模組 2‧‧‧ Blood oxygen concentration measurement module
第1A圖 係為本發明之藥液傳輸裝置之第一方塊示意圖。 Figure 1A is a first block diagram of the drug delivery device of the present invention.
第1B圖係為本發明之藥液傳輸(監控)裝置之外觀示意圖。 Fig. 1B is a schematic view showing the appearance of the drug delivery (monitoring) device of the present invention.
第1C圖係為本發明之藥液傳輸(監控)裝置之結構分解示意圖。 Fig. 1C is a schematic exploded view showing the structure of the chemical liquid transport (monitoring) device of the present invention.
第1D圖 係為本發明之藥液傳輸(監控)裝置之組合示意圖。 Fig. 1D is a schematic diagram showing the combination of the drug delivery (monitoring) device of the present invention.
第2圖 係為本發明之藥液傳輸監控裝置之第二方塊示意圖。 Fig. 2 is a second block diagram showing the liquid medicine transmission monitoring device of the present invention.
第3A圖 係為本發明之藥液傳輸監控裝置之第三方塊示意圖。 Figure 3A is a schematic diagram of a third party block of the medical fluid transport monitoring device of the present invention.
第3B圖 係為本發明之藥液傳輸監控裝置之流量偵 測單元剖面局部結構示意圖。 Figure 3B is a flow detection of the liquid medicine transmission monitoring device of the present invention A schematic diagram of the partial structure of the unit section.
第4圖 係為本發明之藥液傳輸監控裝置之第四方塊示意圖。 Figure 4 is a fourth block diagram of the medical fluid transport monitoring device of the present invention.
第5圖 係為本發明之藥液傳輸監控裝置之第五方塊示意圖。 Fig. 5 is a fifth block diagram showing the liquid medicine transmission monitoring device of the present invention.
請參閱第1A至第1D圖,其係為本發明之藥液傳輸裝置之第一方塊示意圖、藥液傳輸(監控)裝置之外觀示意圖、結構分解示意圖及組合示意圖。圖中,藥液傳輸裝置1包含一可攜式控制本體11及一拆卸式藥液驅動體12。可攜式控制本體11係具有一容置空間111。於此實施例中,可攜式控制本體11更具有二導槽1111、一第一電性接點1112。其中,二導槽1111相對,二導槽1111相鄰於容置空間111且二導槽1111各自與容置空間111連通。此一導槽1111係由殼體頂面軸向延伸後朝另一導槽1111方向彎折延伸而各自形成凸出之L型形體,此導槽1111即由殼體欲延伸之端面及殼體延伸出之L型形體所界定。其中,第一電性接點1112(圖示為一PIN孔)係與容置空間111連通,第一電性接點1112係位於容置空間111且介於兩相互面對之二導槽1111間。 Please refer to FIG. 1A to FIG. 1D , which are a first block diagram of the liquid medicine transport device of the present invention, a schematic diagram of the appearance of the liquid medicine transport (monitoring) device, a schematic structural diagram and a combination diagram. In the figure, the medical fluid transfer device 1 includes a portable control body 11 and a detachable liquid chemical drive body 12. The portable control body 11 has an accommodation space 111. In this embodiment, the portable control body 11 further has two guiding slots 1111 and a first electrical contact 1112. The two guiding grooves 1111 are opposite to each other, and the two guiding grooves 1111 are adjacent to the accommodating space 111 and the two guiding grooves 1111 are respectively communicated with the accommodating space 111. The guiding groove 1111 is axially extended from the top surface of the casing and then bent and extended toward the other guiding groove 1111 to form a convex L-shaped body. The guiding groove 1111 is an end surface and a casing to be extended by the casing. The extended L-shaped body is defined. The first electrical contact 1112 (shown as a PIN hole) is in communication with the accommodating space 111. The first electrical contact 1112 is located in the accommodating space 111 and is located between two mutually facing two guiding slots 1111. between.
拆卸式藥液驅動體12係裝設入可攜式控制本體11上之容置空間111中,拆卸式藥液驅動體12具有一輸液管路121(輸液管路121存有一藥液1211)、一壓電泵浦 122及一資訊傳輸模組123。於此實施例中,拆卸式藥液驅動體12更可具有二導軌120、一開口1201及一第二電性連接點1202。 The detachable liquid chemical driving body 12 is installed in the accommodating space 111 of the portable control body 11, and the detachable liquid chemical driving body 12 has an infusion line 121 (the infusion line 121 stores a liquid 1211), Piezoelectric pump 122 and an information transmission module 123. In this embodiment, the detachable liquid chemical driving body 12 can further have two rails 120, an opening 1201 and a second electrical connection point 1202.
於此實施例中,二導軌120相互面對,開口1201位於二導軌120之間,二導軌120係各自由另一殼體底面軸向延伸後朝另一導軌120之相反方向彎折延伸,而各自形成凸出之L型形體,此導軌120即由朝另一導軌120之相反方向彎折後所延伸之L型形體其中之一邊所界定。第二電性接點1202(圖示為一PIN腳)係位於開口1201內且介於兩相互面對之二導軌120間。上述導軌120係可卡入同方向之導槽1111同時使同方向之第一電性連接點1112及第二電性連接點1202相接觸導通而電性連接。 In this embodiment, the two guide rails 120 face each other, and the opening 1201 is located between the two guide rails 120. The two guide rails 120 are respectively extended from the bottom surface of the other housing and then bent and extended in the opposite direction of the other guide rail 120. Each of the convex L-shaped bodies is formed, and the guide rail 120 is defined by one of the L-shaped bodies extending after being bent in the opposite direction of the other guide rail 120. The second electrical contact 1202 (shown as a PIN pin) is located in the opening 1201 and between the two facing rails 120 facing each other. The guide rails 120 can be engaged with the guide grooves 1111 in the same direction, and the first electrical connection points 1112 and the second electrical connection points 1202 in the same direction are electrically connected to each other.
其中當使用者手持拆卸式藥液驅動體12而組裝入可攜式控制本體11,使可攜式控制本體11提供一電力113經由第一電性接點1112、第二電性接點1202予拆卸式藥液驅動體12,以提供藥液1211傳輸之動力,減少另增加電源所產生之空間及重量,以降低成本支出。上述鄰近於輸液管路121之壓電泵浦122,係可位於輸液管路121內以及位於輸液管路121一側其中之一皆可。於此實施例中,泵浦可為壓電式泵浦122,但不以此為限。藉由個別使用可拋棄式之壓電泵浦122靠近輸液管路121而各自分離獨立(如第3B圖所示),以提供動力使輸液管路121之藥液1211流動,可防止造成藥液1211污染於壓電泵浦122,及避免壓電泵浦122使用年限過久所造成藥液1211流量輸出異常。 When the user holds the detachable liquid chemical driving body 12 and is assembled into the portable control body 11, the portable control body 11 provides a power 113 via the first electrical contact 1112 and the second electrical contact 1202. The detachable liquid medicine driving body 12 is provided to provide power for transferring the liquid medicine 1211, thereby reducing the space and weight generated by the additional power supply, thereby reducing the cost. The piezoelectric pump 122 adjacent to the infusion line 121 can be located in the infusion line 121 and on one side of the infusion line 121. In this embodiment, the pump may be a piezoelectric pump 122, but is not limited thereto. By separately using the disposable piezoelectric pump 122 close to the infusion line 121, the separation is independent (as shown in FIG. 3B) to provide power to flow the liquid 1211 of the infusion line 121, thereby preventing the liquid medicine from being caused. The 1211 is contaminated by the piezoelectric pump 122, and the discharge of the liquid 1212 is abnormal due to the long service life of the piezoelectric pump 122.
請參閱第2圖,其係為本發明之藥液傳輸裝置之第二方塊示意圖。圖中,藥液傳輸監控裝置10包含一可攜式控制本體11及一拆卸式藥液驅動體12。可攜式控制本體11係具有一容置空間111及一控制單元112,控制單元112係控制藥液流量,控制單元112具有一控制訊號1121、一泵浦型號偵測單元1122及複數個藥液傳輸模式1123。 Please refer to FIG. 2, which is a second block diagram of the medical fluid transport device of the present invention. In the figure, the medical fluid transmission monitoring device 10 includes a portable control body 11 and a detachable liquid chemical driving body 12. The portable control unit 11 has a receiving space 111 and a control unit 112. The control unit 112 controls the flow of the liquid medicine. The control unit 112 has a control signal 1121, a pump type detecting unit 1122 and a plurality of liquid chemicals. Transfer mode 1123.
拆卸式藥液驅動體12係由使用者裝設入可攜式控制本體11上之容置空間111中,並且利用可攜式控制本體11提供電力113予拆卸式藥液驅動體12。拆卸式藥液驅動體12具有一輸液管路121(輸液管路121存有一藥液1211)、一壓電泵浦122及一資訊傳輸模組123。壓電泵浦122係提供動力來傳輸輸液管路121內之藥液1211,藉由控制訊號1121控制此泵浦,以控制藥液1211之流量,於此實施例中,泵浦可為壓電式泵浦122,但不以此為限。 The detachable liquid chemical driving body 12 is installed in the accommodating space 111 of the portable control body 11 by the user, and the power 113 is supplied to the detachable liquid chemical driving body 12 by the portable control body 11. The detachable liquid medicine driving body 12 has an infusion line 121 (the infusion line 121 stores a liquid medicine 1211), a piezoelectric pump 122 and an information transmission module 123. The piezoelectric pump 122 provides power to transmit the liquid 1211 in the infusion line 121, and the pump is controlled by the control signal 1121 to control the flow of the liquid 1211. In this embodiment, the pump can be piezoelectric. Pump 122, but not limited to this.
資訊傳輸模組123係具有一泵浦型號識別單元124,泵浦型號識別單元124係提供泵浦之一型號識別碼1241至泵浦型號偵測單元1122,以對應其中之一藥液傳輸模式1123。因此,可攜式控制本體11中之泵浦型號偵測單元1122開始取得拆卸式藥液驅動體12中之泵浦型號識別單元124所提供之一型號識別碼1241。型號識別碼1241代表著各式不同的泵浦類型(藥液傳輸模式1123大致分為藥物操作模式1126(再另設定各式不同型號識別碼1241之麻藥、強心劑等等管制藥物)的泵浦類型、輸血操作模式1124(再另設定各式不同型號識別碼1241之相 異血型之血液)的泵浦類型或者點滴操作模式1125(再另設定各式不同型號識別碼1241之生理食鹽水、葡萄糖液、蛋白液或維生素等等營養物)的泵浦類型,或者,出廠校正資訊(可提供泵浦出廠時之校正基準)。 The information transmission module 123 has a pump model identification unit 124. The pump model identification unit 124 provides a pump type identification code 1241 to a pump model detection unit 1122 to correspond to one of the liquid medicine transmission modes 1123. . Therefore, the pump type detecting unit 1122 in the portable control body 11 starts to obtain one of the model identification codes 1241 provided by the pump model identifying unit 124 in the detachable liquid medicine driving body 12. The model identification code 1241 represents a variety of different pump types (the liquid medicine transmission mode 1123 is roughly divided into the drug operation mode 1126 (and another set of different types of identification code 1241 anesthetics, cardiotonic drugs, etc.) pump type , blood transfusion operation mode 1124 (and then set the different types of different identification code 1241 phase The pump type of the blood of the heteroemia type or the pump type of the drip operation mode 1125 (the other type of different types of identification code 1241 of physiological saline, glucose solution, protein solution or vitamins, etc.), or, Correction information (a calibration reference for the pump at the factory) is available.
拆卸式藥液驅動體11之泵浦型號識別單元124係提供壓電泵浦122之一型號識別碼1241,各式型號識別碼1241係與儲液體(例如儲液袋、儲液瓶或儲液管)內各式類型之藥液(各式藥物、各型血液或各類點滴品)相搭配對應,以提供可攜式控制本體11之泵浦型號偵測單元1122加以偵測辨別,防止病患誤用不相符之藥液導致延誤醫治甚而中毒死亡。拆卸式藥液驅動體12之輸液管路121係連接儲液體之輸液管,於此實施例係以儲液袋及相連之輸液管表示,但不以此為限(如第1B圖所示)。 The pump type identification unit 124 of the detachable liquid medicine driving body 11 provides one type identification code 1241 of the piezoelectric pump 122, and each type identification code 1241 is connected with a liquid (for example, a liquid storage bag, a liquid storage bottle or a liquid storage) Each type of liquid medicine (various drugs, various types of blood or various types of drip products) is matched to provide a pump type detecting unit 1122 of the portable control body 11 for detecting and discriminating, preventing disease Misuse of inconsistent liquids leads to delays in treatment and even poisoning. The infusion line 121 of the detachable liquid medicine driving body 12 is connected to the liquid supply tube. The embodiment is represented by a liquid storage bag and a connected infusion tube, but not limited thereto (as shown in FIG. 1B). .
按照使用者選擇所需要之藥液1211連同已配合之壓電泵浦122,此時,拆卸式藥液驅動體12即裝設入可攜式控制本體11。若泵浦型號偵測單元1122偵測型號識別碼1241不相符時,控制單元112則發出警示訊號1127警告。若泵浦型號偵測單元1122偵測型號識別碼1241符合時,於此同時,控制單元112選擇藥液傳輸模式1123係為各式藥物操作模式、各式輸血操作模式1124或者各式點滴操作模式1125後。可攜式控制本體11即直接進入基本簡化之設定畫面,(每一操作模式內即包括已預設好之「四小時給藥最大量(Four Hour Limit)、單次藥物輸注量(Bolus Amount)、每次給藥間隔時間(Iockout Time),以及設定是否需要持續輸注藥物的「連續輸注量 (Continues Dosage)等等之設定),而不需經過複雜的設定,當藥液1211使用完後即可隨同藥液耗材一起丟棄,故不會使患者使用同一泵浦造成感染,並且方便醫護人員操作。 According to the user's selection of the required chemical solution 1211 together with the piezoelectric pump 122 that has been engaged, the detachable liquid chemical driving body 12 is installed in the portable control body 11. If the pump model detecting unit 1122 detects that the model identification code 1241 does not match, the control unit 112 issues a warning signal 1127 warning. If the pump type detecting unit 1122 detects that the model identification code 1241 is met, at the same time, the control unit 112 selects the liquid medicine transmission mode 1123 as various drug operation modes, various blood transfusion operation modes 1124, or various types of drip operation modes. After 1125. The portable control body 11 directly enters the basic simplified setting screen (including the "Four Hour Limit" and the single drug infusion (Bolus Amount) that have been preset in each operation mode. , Iockout Time, and the number of continuous infusions that require continuous infusion of the drug. (Continues Dosage) and so on), without complicated settings, when the liquid 1211 is used, it can be discarded along with the medical supplies, so it will not cause the patient to use the same pump to cause infection, and it is convenient for medical personnel. operating.
請參閱第3A、3B圖所示,其係為本發明之藥液傳輸監控裝置之第三方塊示意圖及流量偵測單元剖面局部結構示意圖。圖中,第2圖及第1圖之實施方式大致相同,故相同之元件與功效於此不與贅述。圖中不同的是,第2圖中,資訊傳輸模組123更具有一流量偵測單元125,而控制單元112更儲存有複數個流量資料1128。上述流量偵測單元125係產生一藥液流量訊號1252至控制單元112之流量資料1128比對。當藥液流量訊號1252對應其中之一流量資料1128相符時,藥液流量係為正常。當藥液流量訊號1252對應其中之一流量資料1128相異時,藥液流量係為異常,使控制單元112產生一警示訊號1127,用以警示輸液管路121中漏液、阻塞,或者含有空氣等狀況。 Please refer to FIG. 3A and FIG. 3B , which are schematic diagrams of third-party blocks of the liquid medicine transmission monitoring device of the present invention and a partial structure diagram of the flow detecting unit. In the drawings, the embodiments of the second embodiment and the first embodiment are substantially the same, and the same elements and functions are not described herein. The difference is that in the second figure, the information transmission module 123 further has a flow detecting unit 125, and the control unit 112 further stores a plurality of flow data 1128. The flow detecting unit 125 generates a flow rate information 1252 of the chemical liquid flow signal 1252 to the control unit 112. When the drug flow signal 1252 corresponds to one of the flow data 1128, the drug flow is normal. When the liquid flow signal 1252 corresponds to one of the flow data 1128, the flow rate of the liquid is abnormal, and the control unit 112 generates a warning signal 1127 for warning the liquid in the infusion line 121 to leak, block, or contain air. And so on.
此流量偵測單元125可具有預熱器1251、複數溫度感測器1253、1254,藉由藥液1211流經其中之第一溫度感測器1253至第二溫度感測器1254所產生之溫差,據以量測輸液管路121中藥液1211之流量。易言之,以第一溫度感測器1253流入之溫度為基準,當流速慢時,此時藥液1211流經預熱器1251緩慢其加熱時間延長,藥液1211再流入第二溫度感測器1254即可感測而得知溫度大幅提高。反之,當流速快時,此時藥液1211流經預熱器 1251快速其加熱時間短暫,藥液再流入第二溫度感測器1254即可感測而得知溫度些微提高。(藥液1211流入第二溫度感測器1254及預熱器1251間之路徑短,因此散溢之溫度極小可忽略不計)。因此,藥液1211流量大時則溫差小,藥液1211流量小時則溫差大。 The flow detecting unit 125 can have a preheater 1251, a plurality of temperature sensors 1253, 1254, and a temperature difference generated by the first temperature sensor 1253 to the second temperature sensor 1254 flowing through the liquid 1211. According to the measurement, the flow rate of the liquid medicine 1211 in the infusion line 121 is measured. In other words, based on the temperature of the first temperature sensor 1253 flowing in, when the flow rate is slow, the liquid 1211 flows through the preheater 1251 and the heating time is prolonged, and the liquid 1211 flows into the second temperature sensing. The device 1254 can sense the temperature and the temperature is greatly increased. Conversely, when the flow rate is fast, the liquid 1211 flows through the preheater. The 1251 is quickly heated for a short period of time, and the liquid chemical flows into the second temperature sensor 1254 to sense that the temperature is slightly increased. (The path between the chemical solution 1211 flowing into the second temperature sensor 1254 and the preheater 1251 is short, so the temperature of the overflow is extremely negligible). Therefore, when the flow rate of the chemical liquid 1211 is large, the temperature difference is small, and when the flow rate of the chemical liquid 1211 is small, the temperature difference is large.
故,當藥液1211於流動階段,輸液管路121漏液時,則管路中之藥液1211原由流動狀態轉為更高速之流動狀態,因此二溫度感測器溫度之溫度將以預設溫差狀態轉為溫差低之狀態,此時控制單元112產生警示訊號1127以警示醫護人員或病患。當藥液1211於靜止階段時,預熱器1251關閉,防止預熱器1251持續加熱藥液1211。 Therefore, when the liquid medicine 1211 is in the flow phase and the infusion line 121 leaks, the liquid medicine 1211 in the pipeline is originally changed from the flow state to the higher-speed flow state, so the temperature of the second temperature sensor temperature is preset. The temperature difference state is changed to a state in which the temperature difference is low. At this time, the control unit 112 generates a warning signal 1127 to alert the medical staff or the patient. When the chemical solution 1211 is in the stationary phase, the preheater 1251 is turned off, preventing the preheater 1251 from continuously heating the medical solution 1211.
當藥液1211於流動階段,輸液管路121阻塞時則管路中之藥液1211原由流動狀態轉為靜止狀態,因此二溫度感測器溫度之溫度將以有溫差狀態漸趨轉為無溫差狀態,或直接轉為無溫差狀態,此時控制單元112產生警示訊號1127以警示醫護人員或病患:當藥液1211於流動階段,輸液管路121含有空氣時,因空氣抵達預熱器1251無液體介質作為散熱媒介,故管路中之溫度感測器溫度將急遽骤升,此時控制單元112產生警示訊號1127以警示醫護人員或病患。 When the liquid medicine 1211 is in the flow phase and the infusion line 121 is blocked, the liquid medicine 1211 in the pipeline is originally changed from the flowing state to the stationary state, so the temperature of the temperature sensor will gradually change to a temperature-free state in the temperature difference state. The state, or directly to the temperatureless state, the control unit 112 generates a warning signal 1127 to alert the medical staff or the patient: when the liquid 1211 is in the flow phase, the infusion line 121 contains air, and the air arrives at the preheater 1251. The liquid-free medium acts as a heat-dissipating medium, so the temperature of the temperature sensor in the pipeline will rise sharply. At this time, the control unit 112 generates a warning signal 1127 to alert the medical staff or the patient.
此外,可攜式控制本體11更具有一第三電訊連接點1113,拆卸式藥液驅動體12更具有一第四電訊連接點1203。其中,第三電訊連接點1113(圖示為一PIN孔)係與容置空間111連通,第三電訊連接點1113係位於容置 空間且介於兩相互面對之二導槽1111間(如第1C圖所示)。 In addition, the portable control body 11 further has a third telecommunication connection point 1113, and the detachable liquid medicine driving body 12 further has a fourth telecommunication connection point 1203. The third telecommunication connection point 1113 (shown as a PIN hole) is in communication with the accommodating space 111, and the third telecommunication connection point 1113 is located in the accommodating space. The space is between two mutually facing two guiding grooves 1111 (as shown in FIG. 1C).
第四電訊連接點1203(圖示為一PIN腳)係位於開口1201內且介於兩相互面對之二導軌120間。上述導軌120係可卡入導槽1111同時使第三電訊連接點1113及第四電訊連接點1203相接觸導通而電訊連接,致使流量偵測單元125產生一藥液流量訊號1252(藥液流量訊號1252係轉換感測器所感應之溫度)至控制單元112之流量資料1128(流量資料1128係預先設定之溫度代碼)進行比對。(如第1C圖所示)。 The fourth telecommunications connection point 1203 (shown as a PIN pin) is located within the opening 1201 and between the two mutually facing rails 120. The guiding rail 120 can be inserted into the guiding slot 1111 and the third telecommunication connecting point 1113 and the fourth telecommunication connecting point 1203 are electrically connected to each other, so that the flow detecting unit 125 generates a chemical liquid flow signal 1252 (medicine flow signal) The temperature sensed by the 1252 switching sensor is compared to the flow data 1128 of the control unit 112 (the flow data 1128 is a preset temperature code). (as shown in Figure 1C).
請參閱第4圖所示,其係為本發明之藥液傳輸監控裝置之第四方塊示意圖。圖中,第4圖及第3圖之實施方式大致相同,故相同之元件與功效於此不與贅述。圖中不同的是,第3圖中,可攜式控制本體11更具有一插槽114,插槽114係可自由選擇是否增加插設入一血含氧濃度量測模組117(SpO2),以防止患者在昏迷或是無法自主的狀況下發生致命副作用或併發症,尤其藥液傳輸裝置1應用在麻醉藥物(PCA)之外科手術時,病患常併發低血氧症且因為低血氧症容易誘發及加重其他病症之因子。 Please refer to FIG. 4, which is a fourth block diagram of the medical liquid transport monitoring device of the present invention. In the drawings, the embodiments of FIGS. 4 and 3 are substantially the same, and the same elements and functions are not described herein. The difference in the figure is that, in the third figure, the portable control body 11 further has a slot 114, and the slot 114 can be freely selected to be inserted into a blood oxygen concentration measuring module 117 (SpO2). In order to prevent the patient from having a fatal side effect or complication in a coma or incapable condition, especially when the drug delivery device 1 is applied to an anesthetic (PCA) surgery, the patient often has hypoxemia and because of hypoxemia. The disease is easy to induce and aggravate the factors of other diseases.
請參閱第5圖所示,其係為本發明之藥液傳輸監控裝置之第五方塊示意圖。圖中,第5圖及第4圖之實施方式大致相同,故相同之元件與功效於此不與贅述。圖中不同的是,第4圖中,可攜式控制本體11中具有一有/無線傳輸單元115以及控制單元112儲存有一輸液歷程 紀錄資訊1129。藉由有/無線傳輸單元115(例如USB、RS232、Wi-Fi、藍牙、RFID、3G、4G、WiMAX介面之有/無線傳輸方式)傳輸此輸液歷程紀錄資訊1129至外部,以作進一步資訊的分析或閱覽,上述輸液歷程紀錄資訊1129可包含但不限於每次藥液輸出總量紀錄、藥液輸出間隔時間紀錄以及每單位時間藥液輸出值之紀錄,以及生理監控測量之內容紀錄等等。 Please refer to FIG. 5, which is a fifth block diagram of the medical fluid transmission monitoring device of the present invention. In the drawings, the embodiments of the fifth and fourth embodiments are substantially the same, and the same elements and functions are not described herein. The difference in the figure is that, in FIG. 4, the portable control body 11 has a wireless/transmission unit 115 and the control unit 112 stores an infusion process. Record information 1129. The infusion history record information 1129 is transmitted to the outside by the wireless/transmission unit 115 (for example, USB, RS232, Wi-Fi, Bluetooth, RFID, 3G, 4G, WiMAX interface/wireless transmission) for further information. For analysis or reading, the above infusion history record information 1129 may include, but is not limited to, a record of the total output of the drug solution, a record of the interval of the drug solution output, a record of the output value of the drug solution per unit time, and a record of the contents of the physiological monitoring measurement, etc. .
10‧‧‧藥液傳輸監控裝置 10‧‧‧ drug liquid transmission monitoring device
11‧‧‧可攜式控制本體 11‧‧‧Portable Control Body
111‧‧‧容置空間 111‧‧‧ accommodating space
112‧‧‧控制單元 112‧‧‧Control unit
1121‧‧‧控制訊號 1121‧‧‧Control signal
1122‧‧‧泵浦型號偵測單元 1122‧‧‧Pump type detection unit
1123‧‧‧藥液傳輸模式 1123‧‧‧Drug transfer mode
1124‧‧‧輸血操作模式 1124‧‧‧Transfusion mode of operation
1125‧‧‧點滴操作模式 1125‧‧‧ drip operation mode
1126‧‧‧藥物操作模式 1126‧‧‧ drug operation mode
1127‧‧‧警示訊號 1127‧‧‧ warning signal
1128‧‧‧流量資料 1128‧‧‧Flow data
1129‧‧‧輸液歷程紀錄資訊 1129‧‧‧Infusion history record information
113‧‧‧電力 113‧‧‧Power
114‧‧‧插槽 114‧‧‧Slots
115‧‧‧有/無線傳輸單元 115‧‧‧With /Wireless Transmission Unit
12‧‧‧拆卸式藥液驅動體 12‧‧‧Disassembled liquid driving body
121‧‧‧輸液管路 121‧‧‧Infusion line
1211‧‧‧藥液 1211‧‧‧ liquid
122‧‧‧壓電泵浦 122‧‧‧Piezoelectric pump
123‧‧‧資訊傳輸模組 123‧‧‧Information Transmission Module
124‧‧‧泵浦型號識別單元 124‧‧‧Pump Model Identification Unit
1241‧‧‧型號識別碼 1241‧‧‧Model ID
125‧‧‧流量偵測單元 125‧‧‧Flow detection unit
1252‧‧‧藥液流量訊號 1252‧‧‧Drug flow signal
2‧‧‧血含氧濃度量測模組 2‧‧‧ Blood oxygen concentration measurement module
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102143162A TWI566797B (en) | 2013-11-27 | 2013-11-27 | Liquid transmission device and liquid transmission monitoring device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102143162A TWI566797B (en) | 2013-11-27 | 2013-11-27 | Liquid transmission device and liquid transmission monitoring device |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201519922A TW201519922A (en) | 2015-06-01 |
TWI566797B true TWI566797B (en) | 2017-01-21 |
Family
ID=53934746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102143162A TWI566797B (en) | 2013-11-27 | 2013-11-27 | Liquid transmission device and liquid transmission monitoring device |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI566797B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201221169A (en) * | 2010-09-24 | 2012-06-01 | Carefusion 303 Inc | Modular pumping system |
CN203227106U (en) * | 2013-05-07 | 2013-10-09 | 杭州普昂医疗科技有限公司 | Split-type insulin pump |
-
2013
- 2013-11-27 TW TW102143162A patent/TWI566797B/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201221169A (en) * | 2010-09-24 | 2012-06-01 | Carefusion 303 Inc | Modular pumping system |
CN203227106U (en) * | 2013-05-07 | 2013-10-09 | 杭州普昂医疗科技有限公司 | Split-type insulin pump |
Also Published As
Publication number | Publication date |
---|---|
TW201519922A (en) | 2015-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6851360B2 (en) | High performance adapter for injection devices | |
US11464904B2 (en) | Selectively controlling fluid flow through a fluid pathway | |
US20230414863A1 (en) | Device and method for setting therapeutic parameters for an infusion device | |
JP6207516B2 (en) | Infusion pump | |
EP3804782B1 (en) | Flow sensor system with connection assembly | |
AU2014348700B2 (en) | Fluid control system and disposable assembly | |
US9186457B2 (en) | Intravenous infusion monitoring apparatus, system and method | |
EP2925387B1 (en) | Selectively controlling fluid flow through a fluid pathway | |
CN113398377A (en) | Flow sensor system including transmission connection | |
TWI566797B (en) | Liquid transmission device and liquid transmission monitoring device | |
KR20190098802A (en) | Sap monitoring system | |
CN204050510U (en) | Medicinal liquid transmitting device and medicinal liquid transmitting, monitoring device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |